VFINX
Price
$576.51
Change
-$2.24 (-0.39%)
Updated
Jul 15 closing price
Net Assets
1.49T
VPCCX
Price
$36.69
Change
-$0.41 (-1.11%)
Updated
Jul 15 closing price
Net Assets
12.59B
Interact to see
Advertisement

VFINX vs VPCCX

Header iconVFINX vs VPCCX Comparison
Open Charts VFINX vs VPCCXBanner chart's image
Vanguard 500 Index Investor
Price$576.51
Change-$2.24 (-0.39%)
VolumeN/A
Net Assets1.49T
Vanguard PRIMECAP Core I
Price$36.69
Change-$0.41 (-1.11%)
VolumeN/A
Net Assets12.59B
VFINX vs VPCCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VFINX vs. VPCCX commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VFINX is a Buy and VPCCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.49T vs. VPCCX (12.6B). VFINX pays higher dividends than VPCCX: VFINX (1.12) vs VPCCX (0.94). VFINX was incepted earlier than VPCCX: VFINX (49 years) vs VPCCX (21 years). VPCCX (0.43) is less costly to investors than VFINX (0.14). VPCCX is a more actively managed with annual turnover of: 6.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than VPCCX: VFINX (0) vs VPCCX (3000). VFINX annual gain was more profitable for investors over the last year : 11.38 vs. VPCCX (1.43). VFINX return over 5 years is better than : 95.11 vs. VPCCX (43.83).
VFINXVPCCXVFINX / VPCCX
Total Expense Ratio0.140.4333%
Annual Report Gross Expense Ratio0.140.4333%
Fund Existence49 years21 years-
Gain YTD6.63710.94561%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.49T12.6B11,825%
Annual Yield % from dividends1.120.94119%
Returns for 1 year11.381.43797%
Returns for 3 years62.3831.10201%
Returns for 5 years95.1143.83217%
Returns for 10 years195.1668.92283%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LPTX0.33N/A
+1.39%
Leap Therapeutics
PLCE5.040.05
+1.00%
Children's Place
KYMR44.910.01
+0.02%
Kymera Therapeutics
APTV69.30-1.18
-1.67%
Aptiv PLC
IMTX5.96-0.15
-2.45%
Immatics NV